File Download
 
Links for fulltext
(May Require Subscription)
 
Supplementary

Article: Effect of applying the new Clinical and Laboratory Standards Institute ceftazidime and ceftriaxone susceptibility breakpoints for Escherichia coli in Hong Kong
  • Basic View
  • Metadata View
  • XML View
TitleEffect of applying the new Clinical and Laboratory Standards Institute ceftazidime and ceftriaxone susceptibility breakpoints for Escherichia coli in Hong Kong
 
AuthorsHo, PL1
Chow, KH1
Lo, WU1
To, KK1
Cheng, VC1
 
Issue Date2011
 
PublisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/ijantimicag
 
CitationInternational Journal Of Antimicrobial Agents, 2011, v. 37 n. 3, p. 270-271 [How to Cite?]
DOI: http://dx.doi.org/10.1016/j.ijantimicag.2010.11.016
 
ISSN0924-8579
2013 Impact Factor: 4.259
 
DOIhttp://dx.doi.org/10.1016/j.ijantimicag.2010.11.016
 
ISI Accession Number IDWOS:000287476900016
 
ReferencesReferences in Scopus
 
DC FieldValue
dc.contributor.authorHo, PL
 
dc.contributor.authorChow, KH
 
dc.contributor.authorLo, WU
 
dc.contributor.authorTo, KK
 
dc.contributor.authorCheng, VC
 
dc.date.accessioned2011-08-26T14:24:50Z
 
dc.date.available2011-08-26T14:24:50Z
 
dc.date.issued2011
 
dc.description.naturelink_to_subscribed_fulltext
 
dc.identifier.citationInternational Journal Of Antimicrobial Agents, 2011, v. 37 n. 3, p. 270-271 [How to Cite?]
DOI: http://dx.doi.org/10.1016/j.ijantimicag.2010.11.016
 
dc.identifier.citeulike8613766
 
dc.identifier.doihttp://dx.doi.org/10.1016/j.ijantimicag.2010.11.016
 
dc.identifier.epage271
 
dc.identifier.hkuros190826
 
dc.identifier.hkuros209812
 
dc.identifier.isiWOS:000287476900016
 
dc.identifier.issn0924-8579
2013 Impact Factor: 4.259
 
dc.identifier.issue3
 
dc.identifier.openurl
 
dc.identifier.pmid21227656
 
dc.identifier.scopuseid_2-s2.0-79951951930
 
dc.identifier.spage270
 
dc.identifier.urihttp://hdl.handle.net/10722/137427
 
dc.identifier.volume37
 
dc.languageeng
 
dc.publisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/ijantimicag
 
dc.publisher.placeNetherlands
 
dc.relation.ispartofInternational Journal of Antimicrobial Agents
 
dc.relation.referencesReferences in Scopus
 
dc.subject.meshCeftazidime - blood - pharmacology - urine
 
dc.subject.meshCeftriaxone - blood - pharmacology - urine
 
dc.subject.meshEscherichia coli - drug effects - enzymology - isolation and purification
 
dc.subject.meshMicrobial Sensitivity Tests
 
dc.subject.meshbeta-Lactam Resistance
 
dc.titleEffect of applying the new Clinical and Laboratory Standards Institute ceftazidime and ceftriaxone susceptibility breakpoints for Escherichia coli in Hong Kong
 
dc.typeArticle
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Ho, PL</contributor.author>
<contributor.author>Chow, KH</contributor.author>
<contributor.author>Lo, WU</contributor.author>
<contributor.author>To, KK</contributor.author>
<contributor.author>Cheng, VC</contributor.author>
<date.accessioned>2011-08-26T14:24:50Z</date.accessioned>
<date.available>2011-08-26T14:24:50Z</date.available>
<date.issued>2011</date.issued>
<identifier.citation>International Journal Of Antimicrobial Agents, 2011, v. 37 n. 3, p. 270-271</identifier.citation>
<identifier.issn>0924-8579</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/137427</identifier.uri>
<language>eng</language>
<publisher>Elsevier BV. The Journal&apos;s web site is located at http://www.elsevier.com/locate/ijantimicag</publisher>
<relation.ispartof>International Journal of Antimicrobial Agents</relation.ispartof>
<subject.mesh>Ceftazidime - blood - pharmacology - urine</subject.mesh>
<subject.mesh>Ceftriaxone - blood - pharmacology - urine</subject.mesh>
<subject.mesh>Escherichia coli - drug effects - enzymology - isolation and purification</subject.mesh>
<subject.mesh>Microbial Sensitivity Tests</subject.mesh>
<subject.mesh>beta-Lactam Resistance</subject.mesh>
<title>Effect of applying the new Clinical and Laboratory Standards Institute ceftazidime and ceftriaxone susceptibility breakpoints for Escherichia coli in Hong Kong</title>
<type>Article</type>
<identifier.openurl>http://library.hku.hk:4550/resserv?sid=HKU:IR&amp;issn=0924-8579&amp;volume=37&amp;issue=3&amp;spage=270&amp;epage=271&amp;date=2011&amp;atitle=Effect+of+applying+the+New+Clinical+and+Laboratory+Standards+Institute+ceftazidime+and+ceftriaxone+susceptibility+breakpoints+for+Escherichia+coli+in+Hong+Kong</identifier.openurl>
<description.nature>link_to_subscribed_fulltext</description.nature>
<identifier.doi>10.1016/j.ijantimicag.2010.11.016</identifier.doi>
<identifier.pmid>21227656</identifier.pmid>
<identifier.scopus>eid_2-s2.0-79951951930</identifier.scopus>
<identifier.hkuros>190826</identifier.hkuros>
<identifier.hkuros>209812</identifier.hkuros>
<relation.references>http://www.scopus.com/mlt/select.url?eid=2-s2.0-79951951930&amp;selection=ref&amp;src=s&amp;origin=recordpage</relation.references>
<identifier.volume>37</identifier.volume>
<identifier.issue>3</identifier.issue>
<identifier.spage>270</identifier.spage>
<identifier.epage>271</identifier.epage>
<identifier.isi>WOS:000287476900016</identifier.isi>
<publisher.place>Netherlands</publisher.place>
<identifier.citeulike>8613766</identifier.citeulike>
</item>
Author Affiliations
  1. The University of Hong Kong